Evoclin

Babesiosis, Mitral Valve Prolapse, Toxoplasmosis + 39 more

Treatment

20 Active Studies for Evoclin

What is Evoclin

Clindamycin

The Generic name of this drug

Treatment Summary

Clindamycin is an antibiotic used to treat a range of bacterial infections. It can also be used topically to treat acne. Clindamycin has a limited spectrum of activity, meaning it only works against certain types of bacteria. Additionally, it holds some activity against protozoans, and is sometimes used off-label to treat toxoplasmosis, malaria, and babesiosis. Clindamycin is a semi-synthetic version of lincomycin, a naturally occurring lincosamide antibiotic, and is considered to be more effective than its predecessor. The name lincomycin comes from the city

Cleocin Hydrochloride

is the brand name

Evoclin Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cleocin Hydrochloride

Clindamycin

1970

507

Effectiveness

How Evoclin Affects Patients

Clindamycin works by preventing bacteria from creating proteins, which stops them from multiplying. It needs to be taken every six hours to keep the antibiotic effective. Clindamycin can cause a type of diarrhea called Clostridium difficile associated diarrhea (CDAD) which can range from mild diarrhea to life-threatening colitis. This is why clindamycin should only be used for serious infections that cannot be treated with less harmful antibiotics. Clindamycin is effective against many types of bacteria, including both aerobes and anaerobes, however resistance to the drug may develop over time. It is recommended

How Evoclin works in the body

Clindamycin works by blocking bacteria from making proteins. It does this by binding to a part of the bacterial ribosome, which is necessary for protein formation. Clindamycin also has an effect on Propionibacterium acnes, a bacteria linked to acne. It's not clear how it works against acne, but this is likely to be one of the ways.

When to interrupt dosage

The prescribed dosage of Evoclin is contingent upon the diagnosed condition, such as viridans group streptococci, Vaginal Infections and Surgical Intervention. The amount of dosage is contingent upon the delivery approach (e.g. Cream - Vaginal or Suspension - Topical) listed in the table below.

Condition

Dosage

Administration

viridans group streptococci

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Heart Valve Prosthesis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Communicable Diseases

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Respiratory Tract Infections

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Bone and Bones

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Acne Vulgaris

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Endometritis caused by Anaerobic Bacterial Infection

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

prophylaxis of Bacterial endocarditis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Malaria

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

penicillins

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Bacteria, Anaerobic

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Hypertrophic Cardiomyopathy

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Surgical Intervention

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Pneumonia, Pneumocystis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Mixed Vaginal Infections

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Respiratory Tract Infections (RTI) caused by susceptible streptococci

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Skin Structures and Soft Tissue Infections caused by susceptible streptococci

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Bone and Bones

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Heart Defects, Congenital

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Acne Vulgaris

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Warnings

Evoclin Contraindications

Condition

Risk Level

Notes

Enterocolitis, Pseudomembranous

Do Not Combine

Crohn Disease

Do Not Combine

Ulcerative Colitis

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Clindamycin may interact with Pulse Frequency

There are 20 known major drug interactions with Evoclin.

Common Evoclin Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Clindamycin.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Clindamycin.

Bromocriptine

Major

The serum concentration of Bromocriptine can be increased when it is combined with Clindamycin.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Clindamycin.

Cabergoline

Major

The serum concentration of Cabergoline can be increased when it is combined with Clindamycin.

Evoclin Toxicity & Overdose Risk

The toxic dose of clindamycin in mice and rats has been recorded as 2540 mg/kg and 2190 mg/kg respectively. No cases of overdose have been reported, but symptoms could include abdominal pain, nausea, vomiting, and diarrhea. One 3-year-old child was given 100 mg/kg daily for 5 days and only experienced mild abdominal pain and diarrhea. Activated charcoal may be used to remove unabsorbed drug, but hemodialysis and peritoneal dialysis will not be effective. General supportive measures are recommended if someone takes too much clindamycin.

image of a doctor in a lab doing drug, clinical research

Evoclin Novel Uses: Which Conditions Have a Clinical Trial Featuring Evoclin?

Presently, 73 active clinical trials are underway to assess the potential of Evoclin in alleviating Bacterial Endocarditis, Acne and Pneumocystis Jirovecii Pneumonia.

Condition

Clinical Trials

Trial Phases

Respiratory Tract Infections (RTI) caused by susceptible streptococci

0 Actively Recruiting

Acne Vulgaris

3 Actively Recruiting

Phase 1, Phase 2, Early Phase 1, Phase 4

Mitral Valve Prolapse

1 Actively Recruiting

Not Applicable

Hypertrophic Cardiomyopathy

4 Actively Recruiting

Not Applicable, Phase 1, Phase 2

Surgically constructed systemic-pulmonary shunt

0 Actively Recruiting

Respiratory Tract Infections

0 Actively Recruiting

Bacteria, Anaerobic

0 Actively Recruiting

Heart Defects, Congenital

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Bone and Bones

0 Actively Recruiting

Babesiosis

1 Actively Recruiting

Phase 2

Mixed Vaginal Infections

0 Actively Recruiting

Toxoplasmosis

1 Actively Recruiting

Phase 4

Surgical Intervention

0 Actively Recruiting

Pelvic cellulitis caused by Anaerobic Bacterial Infection

0 Actively Recruiting

Bacterial Endocarditis

0 Actively Recruiting

Malaria

0 Actively Recruiting

Acne Vulgaris

0 Actively Recruiting

Vaginal Infections

0 Actively Recruiting

Acquired Immunodeficiency Syndrome

5 Actively Recruiting

Phase 1, Phase 2, Not Applicable

Evoclin Reviews: What are patients saying about Evoclin?

5

Patient Review

8/29/2009

Evoclin for Skin Infection due to a Bacteria

Used this in conjunction with Proactiv Cleanser and it was very effective at minimizing the appearance of large pores.

5

Patient Review

8/29/2009

Evoclin for Acne

This stuff works wonders on acne and blackheads. You'll see a difference in no time flat!

5

Patient Review

5/28/2009

Evoclin for Acne

I've been using this product for acne treatment twice daily for almost three weeks now, and not only has it cleared up my skin, but the pores by my nose and chin that have always been larger have gotten a lot smaller. I'm very happy with this product!

5

Patient Review

4/3/2008

Evoclin for Acne

I've tried a lot of different things to get rid of my acne, but none of them worked as well as Evoclin. I'm really happy with the results.

4.7

Patient Review

6/11/2009

Evoclin for Acne

I used to love this medication because it was so easy and effective, but I think it's stopped working for me.

4.3

Patient Review

2/10/2010

Evoclin for Acne

I'm 28 and I have chest acne. I'm on week 2 and I see a significant reduction in my acne. My skin is not irritated or dry, which is amazing.

3.3

Patient Review

6/3/2008

Evoclin for Acne

I'm a teenager with acne. I sought treatment for it, and while this did eventually help dry out my skin, it wasn't as effective as other treatments I've tried since then.

1.7

Patient Review

3/24/2011

Evoclin for Skin Infection due to a Bacteria

I didn't see any reduction in the number of sores on my scalp.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about evoclin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What does clindamycin do for acne?

"Topical clindamycin is a medication used to treat acne. Clindamycin is an antibiotic that works by stopping the growth of bacteria that cause acne."

Answered by AI

Who makes Evoclin?

"Suspected adverse reactions should be reported to Stiefel Laboratories, Inc. at 1-888-784-3335 (1-888-STIEFEL) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch."

Answered by AI

What does clindamycin gel do?

"Topical clindamycin is a medication used to treat acne. It is usually applied to the skin once or twice a day. It may be used alone or in combination with other acne treatments. Topical clindamycin may also be used to treat other conditions as prescribed by a doctor. Clindamycin requires a doctor's prescription."

Answered by AI

What is evoclin used for?

"This acne medication helps to reduce the number of pimples by using the antibiotic clindamycin to kill bacteria."

Answered by AI

Clinical Trials for Evoclin

Image of New Jersey Community Research Initiative in Newark, United States.

AI-DBT for Suicide Prevention in HIV/AIDS

18+
All Sexes
Newark, NJ

One in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address suicide prevention for older PLWHA, despite their unique biopsychosocial and structural risk factors. Through this work, investigators will adapt Dialectical Behavior Therapy, an evidence-based intervention for suicide prevention, for patients with PLWHA to be delivered by an AI-powered conversational Agent developed by our industry partner, Empower Health. Investigators will then pilot test the feasibility, usability, acceptability and preliminary efficacy to improve self-efficacy to manage negative emotions in n=50 older adults living with HIV/AIDS.

Recruiting
Has No Placebo

New Jersey Community Research Initiative (+1 Sites)

Elissa Kozlov, PhD

Image of McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital in Montreal, Canada.

Systemic Corticosteroids for Pneumocystis Pneumonia

18+
All Sexes
Montreal, Canada

The HOW LONG trial is an international, multicenter, Phase IV randomized clinical trial evaluating the optimal duration of adjunctive systemic corticosteroids in immunocompromised adults with severe Pneumocystis jirovecii pneumonia (PCP) who demonstrate early clinical recovery. Participants who no longer require supplemental oxygen by day 10 of corticosteroid therapy are randomized to discontinue corticosteroids at day 10 (or hospital discharge, if earlier) versus continue corticosteroids for a total of 21 days. The trial assesses whether earlier discontinuation reduces steroid-related complications while maintaining clinical outcomes.

Phase 4
Waitlist Available

McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital

Image of Los Angeles General Medical Center in Los Angeles, United States.

Decision Support Tool for HIV Treatment

18+
All Sexes
Los Angeles, CA

This study is testing software designed to help healthcare providers choose the best HIV treatment combinations for their patients. HIV medicines, known as antiretroviral therapy (ART), can be complex to manage because the right regimen depends on many factors-such as drug resistance, other health conditions, and medication schedules. Many people with HIV are cared for by general clinicians who may not have access to HIV specialists, which can make treatment decisions more challenging. In this study, healthcare providers will use patient cases to compare standard HIV treatment resources with a new clinical decision support tool that gives evidence-based ART recommendations at the point of care. The investigators hypothesize that using the tool will help providers select treatment plans that better match clinical guidelines, make decisions faster, reduce mental effort, and increase overall satisfaction with the prescribing process.

Waitlist Available
Has No Placebo

Los Angeles General Medical Center

Hayoun Lee, PhD

Have you considered Evoclin clinical trials?

We made a collection of clinical trials featuring Evoclin, we think they might fit your search criteria.
Go to Trials
Image of Montefiore Medical Center in Bronx, United States.

myPACE+ Algorithm for Hypertrophic Cardiomyopathy

18+
All Sexes
Bronx, NY

This will be a two-arm investigator-initiated randomized controlled study of patients with nHCM and LV ejection fraction ≥50% and NYHA II-III symptoms, normal intrinsic conduction system and pre-existing suitable dual-chamber implantable cardioverter defibrillators (ICD) systems. Patients will be randomly assigned to either personalized accelerated pacing (using the myPACE+ algorithm with mono-fractional exponent) or usual care groups. At baseline and after 3 months of pacing all patients will undergo a CPET, echocardiogram, blood work for NT-proBNP levels and complete the KCCQ-OSS and HCMSQ, questionnaires. The investigator team hypothesizes that personalized accelerated pacing will be safe and improve symptoms and heart-failure related quality of life, physical activity, pVO2, biomarkers (i.e. NT-proBNP), diastolic parameters and cardiac structure.

Recruiting
Has No Placebo

Montefiore Medical Center (+1 Sites)

Sandhya Murthy, MD

Medtronic

Image of Texas Tech University Health Sciences Center in Lubbock, United States.

Amoxicillin Challenge for Penicillin Allergy

18 - 89
All Sexes
Lubbock, TX

The goal of this clinical trial is to learn about dosing when testing to see if a penicillin allergy label can be removed from adults that had been labeled as "penicillin-allergic" previously. The main question it aims to answer is: \- In penicillin-allergic patients that are at low risk of having an allergic reaction, is a one-dose oral challenge with amoxicillin (a penicillin-based antibiotic) as safe and effective as a two-dose oral challenge? Participants will, after being identified as having a low-risk penicillin allergy, be administered oral amoxicillin in a controlled setting and then monitored for an allergic reaction. Researchers will compare participants that took one dose of amoxicillin to participants that took two doses of amoxicillin (a small dose and then a larger dose) to see if either group was more likely to develop an allergic reaction.

Phase 3
Recruiting

Texas Tech University Health Sciences Center

James A Tarbox, MD

Have you considered Evoclin clinical trials?

We made a collection of clinical trials featuring Evoclin, we think they might fit your search criteria.
Go to Trials
Image of University of California - San Francisco in San Francisco, United States.

Exercise Program for Hypertrophic Cardiomyopathy

18 - 80
All Sexes
San Francisco, CA

The EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on the improvement of HCM-related symptoms and cardiac function. About 70 participants will be recruited and randomized on a 1:1 ratio to either moderate intensity training or usual physicial activity interventions. Patients will be followed during a period of 24 weeks and assesesments as physical examination, questionnaires, 12 lead ecg's, biomarker levels, echocardiogram, Cardiac Magnetic resonance, PET and CPET will be performed to evaluate their response to the intervention.

Recruiting
Has No Placebo

University of California - San Francisco

Theodore P Abraham, M.D

Have you considered Evoclin clinical trials?

We made a collection of clinical trials featuring Evoclin, we think they might fit your search criteria.
Go to Trials